Sanofi to sell the drugs factory Zentiva from Bucharest

Newsroom 01/11/2016 | 11:20

The French group Sanofi intends to sell the generic drugs division from Europe, which will have effects also on the Romanian market, with Zentiva factory being owned by Sanofi since 2009 and being put up for sale mow, according to a release published on the Bucharest Stock Exchange.

The announcement made at the same time with the launch of the 2020 strategy. Sanofi has carefully analyzed all the available options regarding the future of the strategy of the generic division in Europe and decided to start the separation process.

„The generics activity remains an important one for Sanofi in other parts of the world, continuing to consolidate the contribution in this domain in the emergent markets, ” says Emmanuelle Valentin, the president of the Administration Council of Zentiva.

Georgiana Bendre

BR Magazine | Latest Issue

Download PDF or read online: September 2022 Issue | Business Review Magazine

The September 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Transilvania Investments paves its way to a sustainable
Newsroom | 21/09/2022 | 14:17

You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

I agree with the Privacy policy of business-review.eu
I agree with the storage and handling of my data by business-review.eu

Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue